Publications found:
73,128
Sort by:
Asthma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Asthma (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Asthma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
811 pages
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
576 pages
Osteoporosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Osteoporosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoporosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
375 pages
Allergic Rhinitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Allergic Rhinitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Allergic Rhinitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
204 pages
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2020
US$ 2,000.00
... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Chronic Kidney Disease (Chronic Renal Failure) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
326 pages
Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Idiopathic Pulmonary Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Idiopathic Pulmonary Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
539 pages
Acne Vulgaris - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Acne Vulgaris (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Acne Vulgaris and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
217 pages
Endometriosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Endometriosis (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Endometriosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
156 pages
Osteoarthritis Pain - Pipeline Review, H2 2020
US$ 2,000.00
... . The Osteoarthritis Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
233 pages
Premature Ejaculation - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Premature Ejaculation (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Premature Ejaculation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
42 pages
Cystic Fibrosis - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Cystic Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cystic Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
550 pages
Ulcerative Colitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Ulcerative Colitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Ulcerative Colitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
779 pages
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Adrenocortical Carcinoma (Adrenal Cortex Cancer) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Adrenocortical Carcinoma (Adrenal Cortex Cancer) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
204 pages
Oropharyngeal Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Oropharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Oropharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
724 pages
Chronic Urticaria Or Hives - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Chronic Urticaria Or Hives (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Chronic Urticaria Or Hives and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
152 pages
Sickle Cell Disease - Pipeline Review, H2 2020
US$ 2,000.00
... . The Sickle Cell Disease (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sickle Cell Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
308 pages
Vitiligo - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Vitiligo (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Vitiligo and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
158 pages
Post Menopausal Osteoporosis - Pipeline Review, H2 2020
US$ 2,000.00
... . The Post Menopausal Osteoporosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Post Menopausal Osteoporosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
131 pages
Allergic Conjunctivitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Allergic Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Allergic Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
113 pages
Angina (Angina Pectoris) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Angina (Angina Pectoris) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Angina (Angina Pectoris) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
89 pages
Bronchiectasis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Bronchiectasis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchiectasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
110 pages
Critical Limb Ischemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Critical Limb Ischemia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Critical Limb Ischemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
166 pages
Overactive Bladder - Pipeline Review, H2 2020
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Overactive Bladder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
134 pages
Polycystic Kidney Disease - Pipeline Review, H2 2020
US$ 2,000.00
... . The Polycystic Kidney Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Polycystic Kidney Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
144 pages
Rabies - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Rabies (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rabies and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
108 pages
Retinoblastoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Retinoblastoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Retinoblastoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
72 pages
Rosacea - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Rosacea (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Rosacea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
98 pages
Gastroenteritis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Gastroenteritis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Gastroenteritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
103 pages
Keratitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Keratitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Keratitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
90 pages
Pheochromocytoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Pheochromocytoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Pheochromocytoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
161 pages
Pompe Disease - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Pompe Disease (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Pompe Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
104 pages
Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Basal Cell Carcinoma (Basal Cell Epithelioma) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Basal Cell Carcinoma (Basal Cell Epithelioma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
487 pages
Japanese Encephalitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Japanese Encephalitis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Japanese Encephalitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
46 pages
Essential Thrombocythemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Essential Thrombocythemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Essential Thrombocythemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
121 pages
Fallopian Tube Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Fallopian Tube Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Fallopian Tube Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
1722 pages
Hepatocyte Growth Factor - Pipeline Review, H2 2020
US$ 3,500.00
... releases. The Hepatocellular Carcinoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hepatocellular Carcinoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
84 pages
Organophosphate and Carbamate Poisoning - Pipeline Review, H2 2020
US$ 2,000.00
... . The Organophosphate and Carbamate Poisoning (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Organophosphate and Carbamate Poisoning and features dormant and discontinued projects. The guide covers therapeutics under Development ...
October 2020
34 pages
Stroke - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Stroke (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Stroke and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
773 pages
Atherosclerosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Atherosclerosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Atherosclerosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
268 pages
Corneal Neovascularization - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Corneal Neovascularization (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Corneal Neovascularization and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
43 pages
Eosinophilic Esophagitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Eosinophilic Esophagitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Eosinophilic Esophagitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
151 pages
Hepatitis D - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hepatitis D (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis D and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
102 pages
Yellow Fever - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Yellow Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Yellow Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
71 pages
Ureter Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Ureter Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ureter Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
363 pages
Kidney Fibrosis - Pipeline Review, H2 2020
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Kidney Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
187 pages
Measles - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Measles (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Measles and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
49 pages
Optic Neuritis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Optic Neuritis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Optic Neuritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
54 pages
Peanut Allergy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Peanut Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Peanut Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
170 pages
Rotavirus Infections - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Rotavirus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rotavirus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
58 pages
